A citation-based method for searching scientific literature

Erin O Wissler Gerdes, Yi Zhu, Tamar Tchkonia, James L Kirkland. FEBS J 2020
Times Cited: 55







List of co-cited articles
555 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity.
Virginie Clement, Pilar Sanchez, Nicolas de Tribolet, Ivan Radovanovic, Ariel Ruiz i Altaba. Curr Biol 2007
817
1


Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
Qianghu Wang, Baoli Hu, Xin Hu, Hoon Kim, Massimo Squatrito, Lisa Scarpace, Ana C deCarvalho, Sali Lyu, Pengping Li, Yan Li,[...]. Cancer Cell 2017
728
1

Multifaceted resistance of gliomas to temozolomide.
Dora B Bocangel, Sydney Finkelstein, S Clifford Schold, Kishor K Bhakat, Sankar Mitra, Demetrius M Kokkinakis. Clin Cancer Res 2002
115
1

Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
Su Yeon Lee, Eui Kyong Jeong, Min Kyung Ju, Hyun Min Jeon, Min Young Kim, Cho Hee Kim, Hye Gyeong Park, Song Iy Han, Ho Sung Kang. Mol Cancer 2017
243
1

Overexpression of FADD and Caspase-8 inhibits proliferation and promotes apoptosis of human glioblastoma cells.
Hong-Bin Wang, Tao Li, Dong-Zhou Ma, Yan-Xin Ji, Hua Zhi. Biomed Pharmacother 2017
10
10

Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.
Jaclyn LoPiccolo, Gideon M Blumenthal, Wendy B Bernstein, Phillip A Dennis. Drug Resist Updat 2008
602
1

The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of ATR-Chk1 Signaling.
Chenghao Peng, Zhengxin Chen, Shuai Wang, Hong-Wei Wang, Wenjin Qiu, Lin Zhao, Ran Xu, Hui Luo, Yuanyuan Chen, Dan Chen,[...]. Cancer Res 2016
37
2

Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect.
Kiran Kumar Velpula, Arnima Bhasin, Swapna Asuthkar, Andrew J Tsung. Cancer Res 2013
85
1

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities.
Sejin Oh, Jeonghun Yeom, Hee Jin Cho, Ju-Hwa Kim, Seon-Jin Yoon, Hakhyun Kim, Jason K Sa, Shinyeong Ju, Hwanho Lee, Myung Joon Oh,[...]. Nat Commun 2020
18
5

Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma.
Zihao Wang, Lu Gao, Xiaopeng Guo, Chenzhe Feng, Wei Lian, Kan Deng, Bing Xing. Aging (Albany NY) 2019
47
2

Temozolomide: mechanisms of action, repair and resistance.
Jihong Zhang, Malcolm F G Stevens, Tracey D Bradshaw. Curr Mol Pharmacol 2012
431
1

Contribution of the Wnt Pathway to Defining Biology of Glioblastoma.
Marton Tompa, Ferenc Kalovits, Adam Nagy, Bernadette Kalman. Neuromolecular Med 2018
22
4


TP53 gain-of-function mutation promotes inflammation in glioblastoma.
Seok Won Ham, Hee-Young Jeon, Xiong Jin, Eun-Jung Kim, Jun-Kyum Kim, Yong Jae Shin, Yeri Lee, Se Hoon Kim, Seon Yong Lee, Sunyoung Seo,[...]. Cell Death Differ 2019
78
1

Influence of autophagy on the efficacy of radiotherapy.
Shing Yau Tam, Vincent Wing Cheung Wu, Helen Ka Wai Law. Radiat Oncol 2017
53
1

The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2.
Tracy J Berg, Carolina Marques, Vasiliki Pantazopoulou, Elinn Johansson, Kristoffer von Stedingk, David Lindgren, Pauline Jeannot, Elin J Pietras, Tobias Bergström, Fredrik J Swartling,[...]. Cancer Res 2021
11
9

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, Victoria Wang, Yuan Qi, Matthew D Wilkerson, C Ryan Miller, Li Ding, Todd Golub, Jill P Mesirov,[...]. Cancer Cell 2010
1

HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells.
Marianna Colamaio, Nadia Tosti, Francesca Puca, Alessia Mari, Rosaria Gattordo, Yalçın Kuzay, Antonella Federico, Anna Pepe, Daniela Sarnataro, Elvira Ragozzino,[...]. Expert Opin Ther Targets 2016
27
3

p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts.
Eduard B Dinca, Kan V Lu, Jann N Sarkaria, Russell O Pieper, Michael D Prados, Daphne A Haas-Kogan, Scott R Vandenberg, Mitchel S Berger, C David James. Cancer Res 2008
38
2

Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.
Damian Stichel, Azadeh Ebrahimi, David Reuss, Daniel Schrimpf, Takahiro Ono, Mitsuaki Shirahata, Guido Reifenberger, Michael Weller, Daniel Hänggi, Wolfgang Wick,[...]. Acta Neuropathol 2018
112
1

Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell Regulation.
Jacqueline Nathansen, Felix Meyer, Luise Müller, Marc Schmitz, Kerstin Borgmann, Anna Dubrovska. Cancers (Basel) 2021
3
33

NADPH Oxidase as a Target for Modulation of Radiation Response; Implications to Carcinogenesis and Radiotherapy.
Keywan Mortezaee, Nasser Hashemi Goradel, Peyman Amini, Dheyauldeen Shabeeb, Ahmed Eleojo Musa, Masoud Najafi, Bagher Farhood. Curr Mol Pharmacol 2019
43
2

Therapeutic potential of marine peptides in glioblastoma: Mechanistic insights.
Salman Ahmed, Muhammad Mohtasheemul Hasan, Michael Aschner, Hamed Mirzaei, Waqas Alam, Syed Muhammad Mukarram Shah, Haroon Khan. Cell Signal 2021
5
20


Ras-dependent induction of HIF-1alpha785 via the Raf/MEK/ERK pathway: a novel mechanism of Ras-mediated tumor promotion.
Ji-Hong Lim, Eun-Seo Lee, Ho-Jin You, Jung Weon Lee, Jong-Wan Park, Yang-Sook Chun. Oncogene 2004
78
1

Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas.
Massimo Squatrito, Cameron W Brennan, Karim Helmy, Jason T Huse, John H Petrini, Eric C Holland. Cancer Cell 2010
168
1

Autophagy and autophagy-related proteins in cancer.
Xiaohua Li, Shikun He, Binyun Ma. Mol Cancer 2020
295
1

The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells.
Seung Woo Lee, Hyun-Kyung Kim, Na-Hyeon Lee, Hee-Yeon Yi, Hong-Sug Kim, Sung Hee Hong, Yong-Kil Hong, Young Ae Joe. Cancer Lett 2015
71
1

DNA repair inhibition: a selective tumour targeting strategy.
Srinivasan Madhusudan, Ian D Hickson. Trends Mol Med 2005
71
1

Extracellular Vesicles Secreted by Glioma Stem Cells Are Involved in Radiation Resistance and Glioma Progression.
Chenkai Ma, Hong P T Nguyen, Jordan J Jones, Stanley S Stylli, Clarissa A Whitehead, Lucy Paradiso, Rodney B Luwor, Zammam Areeb, Eric Hanssen, Ellie Cho,[...]. Int J Mol Sci 2022
4
25

Somatic mutations of PTEN in glioblastoma multiforme.
S I Wang, J Puc, J Li, J N Bruce, P Cairns, D Sidransky, R Parsons. Cancer Res 1997
452
1

Polymorphisms in autophagy genes are genetic susceptibility factors in glioblastoma development.
E Bueno-Martínez, M Lara-Almunia, C Rodríguez-Arias, A Otero-Rodríguez, S Garfias-Arjona, R González-Sarmiento. BMC Cancer 2022
3
33

Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.
H Fujisawa, R M Reis, M Nakamura, S Colella, Y Yonekawa, P Kleihues, H Ohgaki. Lab Invest 2000
117
1

Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein.
Alessandro Raso, Donatella Vecchio, Enrico Cappelli, Monica Ropolo, Alessandro Poggi, Paolo Nozza, Roberto Biassoni, Samantha Mascelli, Valeria Capra, Fotios Kalfas,[...]. Brain Pathol 2012
32
3

Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
Haiyan Wang, Shanbao Cai, Barbara J Bailey, M Reza Saadatzadeh, Jixin Ding, Eva Tonsing-Carter, Taxiarchis M Georgiadis, T Zachary Gunter, Eric C Long, Robert E Minto,[...]. J Neurosurg 2017
21
4

Chloroquine-induced glioma cells death is associated with mitochondrial membrane potential loss, but not oxidative stress.
Alexandre Teixeira Vessoni, Annabel Quinet, Leonardo Carmo de Andrade-Lima, Davi Jardim Martins, Camila Carrião Machado Garcia, Clarissa Ribeiro Reily Rocha, Debora Braga Vieira, Carlos Frederico Martins Menck. Free Radic Biol Med 2016
18
5

ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation.
Y Kouroku, E Fujita, I Tanida, T Ueno, A Isoai, H Kumagai, S Ogawa, R J Kaufman, E Kominami, T Momoi. Cell Death Differ 2007
718
1

The Role of MicroRNAs in Therapeutic Resistance of Malignant Primary Brain Tumors.
Ilgiz Gareev, Ozal Beylerli, Yanchao Liang, Huang Xiang, Chunyang Liu, Xun Xu, Chao Yuan, Aamir Ahmad, Guang Yang. Front Cell Dev Biol 2021
9
11


Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expression.
Daniela Hanisch, Andrea Krumm, Tamara Diehl, Carla M Stork, Mario Dejung, Falk Butter, Ella Kim, Walburgis Brenner, Gerhard Fritz, Thomas G Hofmann,[...]. Cell Death Dis 2022
1
100



An emerging role of mTOR in lipid biosynthesis.
Mathieu Laplante, David M Sabatini. Curr Biol 2009
410
1

Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma.
Michael D Blough, Desiree C Beauchamp, Morgan R Westgate, John J Kelly, J Gregory Cairncross. J Neurooncol 2011
66
1


Expression of EGFRvIII in glioblastoma: prognostic significance revisited.
Nicola Montano, Tonia Cenci, Maurizio Martini, Quintino Giorgio D'Alessandris, Federica Pelacchi, Lucia Ricci-Vitiani, Giulio Maira, Ruggero De Maria, Luigi Maria Larocca, Roberto Pallini. Neoplasia 2011
94
1

IDH mutations in glioma and acute myeloid leukemia.
Lenny Dang, Shengfang Jin, Shinsan M Su. Trends Mol Med 2010
245
1

Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide.
José L McFaline-Figueroa, Christian J Braun, Monica Stanciu, Zachary D Nagel, Patrizia Mazzucato, Dewakar Sangaraju, Edvinas Cerniauskas, Kelly Barford, Amanda Vargas, Yimin Chen,[...]. Cancer Res 2015
70
1

KML001, a telomere-targeting drug, sensitizes glioblastoma cells to temozolomide chemotherapy and radiotherapy through DNA damage and apoptosis.
Seon Rang Woo, Yunhee Ham, Wonyoung Kang, Heekyoung Yang, Sujong Kim, Juyoun Jin, Kyeung Min Joo, Do-Hyun Nam. Biomed Res Int 2014
21
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.